Regulon

Regulon: R-3515

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
14-0.60597610Pr-122Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
54626 ENSG00000069812 HES2 Q9Y543
634 ENSG00000079385 CEACAM1 P13688
1053 ENSG00000092067 CEBPE Q15744
8808 ENSG00000115598 IL1RL2 Q9HB29
11126 ENSG00000117281 CD160 Q6FH89
79924 ENSG00000128165 ADM2 Q7Z4H4
11173 ENSG00000136378 ADAMTS7 Q9UKP4
3662 ENSG00000137265 IRF4 Q15306
8482 ENSG00000138623 SEMA7A O75326
939 ENSG00000139193 CD27 P26842
5731 ENSG00000160951 PTGER1 P34995
5729 ENSG00000168229 PTGDR Q13258
10316 ENSG00000171596 NMUR1 Q9HB89
6899 ENSG00000184058 TBX1 Q152R5

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ALPROSTADILPTGER2Small moleculeAGONISTProstanoid EP1 receptor agonist40
VIDUPIPRANTPTGDRSmall moleculeANTAGONISTProstanoid DP receptor antagonist20
DINOPROSTONEPTGER1Small moleculeAGONISTProstaglandin E2 receptor agonist40
IMSIDOLIMABIL1RL2AntibodyANTAGONISTIL36 receptor antagonist20
VARLILUMABCD27AntibodyAGONISTCD27 antigen agonist22
ONO-8539PTGER1Small moleculeANTAGONISTProstanoid EP1 receptor antagonist20
ASAPIPRANTPTGDRSmall moleculeANTAGONISTProstanoid DP receptor antagonist30
LAROPIPRANTPTGDRSmall moleculeANTAGONISTProstanoid DP receptor antagonist30
SPESOLIMABIL1RL2AntibodyANTAGONISTIL36 receptor antagonist30

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3515

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs